<< Read Full Article
<< Read Full Article
Third Point Grabs CV Stake
Hedge fund investor Third Point appears to be high on biopharmaceutical company CV Therapeutics(CVTX Quote).
Third Point, run by manager Daniel Loeb, piled about $51 million into the Palo Alto, Calif.-based drug company. Over the last two months it bought 5.9 million shares, representing a nearly 10% stake in CV Therapeutics.
An external spokesman for Third Point declined to comment. A CV Therapeutics spokesman declined to comment. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,366.15 | 1,099.92 | 2,173.14 | 33.80 |
Oil *
77.73
|
|
DOWN
86.53
|
DOWN
9.32
|
DOWN
11.89
|
UP
0.57
|
10 Yr
3.38%
SPDR Gold
118.70
|
|
-0.83%
|
-0.84%
|
-0.54%
|
+1.72%
|
Data delayed 20 minutes |
Connect with TheStreet